Knocking-in Chlamydomonas reinhardtii genes with CRISPR/Cas
The Pigino Group presents a CRISPR/Cas-based protocol for the targeted insertion of exogenous genes in the unicellular green alga Chlamydomonas that is amenable to rapid high-throughput screening of mutant cells.
Chlamydomonas reinhardtii is a widely used simple model organism: in its vegetative state, the alga is haploid (i.e., it harbours a single set of chromosomes) thereby being a valuable model for functional genetics studies.
The CRISPR/Cas system is a tool for editing the genome of living organisms and has been successfully used to functionally inactivate genes in many species, including Chlamydomonas. Loss of function of a given gene in Chlamydomonas can be rescued by introducing an exogenous functional copy of such gene, which can be fused with a tag for further biochemical and/or imaging studies. Chlamydomonas can only randomly incorporate exogenous DNA into its genome via non-homologous end joining (NHEJ). However, the insertion of large stretches of exogenous DNA is a rare event and can disrupt the Chlamydomonas genome at unknown sites. In addition, NHEJ recombination does not guarantee the proper orientation of the insert.
Adrian Nievergelt and Gaia Pigino from the Human Technopole Structural Biology Research Centre devised a method for scarless knock-in mutagenesis in Chlamydomonas. The protocol is based on homology-directed repair (HDR) and the CRISPR/Cas system, which facilitate the correct orientation and precise insertion of the exogenous DNA fragment into the Chlamydomonas genome. The researchers constructed a series of vectors to obtain purified exogenous DNA cassettes for positive selection flanked by homologous sequences to be electroporated along with Cas ribonucleoproteins into Chlamydomonas. Knock-in cells could easily be selected by using antibiotics followed by Fluorescence Activated Cell Sorting (FACS) of the mutant cells and ensuing high-throughput screening by quantitative PCR. The method is now published in Cell Reports Methods.
In summary, Nievergelt and Pigino show that their method may be successfully used to produce knock-in cell lines in a few weeks. Such an approach will find wide use in various Chlamydomonas labs that use these cells to study different aspects of biology, from cilia and ciliopathies to cell division and photosynthesis.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.